BackCara Therapeutics Overview

Cara Therapeutics Total Assets

Latest total assets for CARA: $18M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$17.52M
59.96% YoYΔ $-26.23M vs prior year quarter

Peer trimmed avg / median

Loading

Cara Therapeutics Total Assets History

Loading

Cara Therapeutics vs. peers: Total Assets Comparison

Loading

Cara Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cara Therapeutics (CARA) FAQ

As of the most recent data (June 2026), CARA shows a total assets of $18M. That compares with $44M in the prior-year period — down 60.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CARA's total assets is now $18M (was $44M) — a 60.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cara Therapeutics is outperforming or lagging.

Tracking CARA's total assets over time shows whether Cara Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $18M That compares with $44M in the prior-year period — down 60.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Cara Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $18M) with ownership activity and broader fundamentals.

Cara Therapeutics's total assets is $18M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.